IM Cannabis Management
Management criteria checks 3/4
IM Cannabis' CEO is Oren Shuster, appointed in Oct 2019, has a tenure of 5.08 years. total yearly compensation is CA$808.07K, comprised of 58.9% salary and 41.1% bonuses, including company stock and options. directly owns 13.98% of the company’s shares, worth $607.97K. The average tenure of the management team and the board of directors is 3.2 years and 2.2 years respectively.
Key information
Oren Shuster
Chief executive officer
CA$808.1k
Total compensation
CEO salary percentage | 58.9% |
CEO tenure | 5.1yrs |
CEO ownership | 14.0% |
Management average tenure | 3.2yrs |
Board average tenure | 2.2yrs |
Recent management updates
Recent updates
IM Cannabis Shareholder Rafael Gabay raises stake
Sep 08IM Cannabis GAAP EPS of -C$0.30, revenue of C$23.8M
Aug 15IM Cannabis receives non-compliance notification from Nasdaq for minimum bid price requirement
Jul 19cbdMD And IM Cannabis Partner To Sell CBD Products In Israeli Markets
Aug 14IM Cannabis proposes public offering of securities
May 05IM Cannabis acquires Israel's largest retail and online pharmacy business from Panaxia
Apr 30CEO Compensation Analysis
Date | Total Compensation | Salary | Company Earnings |
---|---|---|---|
Jun 30 2024 | n/a | n/a | -CA$14m |
Mar 31 2024 | n/a | n/a | -CA$15m |
Dec 31 2023 | CA$808k | CA$476k | -CA$9m |
Sep 30 2023 | n/a | n/a | -CA$15m |
Jun 30 2023 | n/a | n/a | -CA$17m |
Mar 31 2023 | n/a | n/a | -CA$17m |
Dec 31 2022 | CA$2m | CA$506k | -CA$23m |
Sep 30 2022 | n/a | n/a | -CA$22m |
Jun 30 2022 | n/a | n/a | -CA$16m |
Mar 31 2022 | n/a | n/a | -CA$10m |
Dec 31 2021 | CA$2m | CA$516k | CA$91k |
Sep 30 2021 | n/a | n/a | -CA$10m |
Jun 30 2021 | n/a | n/a | -CA$12m |
Mar 31 2021 | n/a | n/a | -CA$24m |
Dec 31 2020 | CA$742k | CA$424k | -CA$29m |
Sep 30 2020 | n/a | n/a | -CA$7m |
Jun 30 2020 | n/a | n/a | -CA$10m |
Mar 31 2020 | n/a | n/a | -CA$982k |
Dec 31 2019 | CA$2m | CA$357k | -CA$7m |
Compensation vs Market: Oren's total compensation ($USD582.97K) is about average for companies of similar size in the US market ($USD653.16K).
Compensation vs Earnings: Oren's compensation has been consistent with company performance over the past year.
CEO
Oren Shuster
5.1yrs
Tenure
CA$808,068
Compensation
Mr. Oren Shuster serves as the Co-owner of IMC Ltd. Mr. Shuster serves as Chief Executive Officer and Director of IM Cannabis Corp. since October 11, 2019. Mr. Shuster is a leading figure in the medical ca...
Leadership Team
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
CEO & Director | 5.1yrs | CA$808.07k | 13.98% $ 608.0k | |
Chief Financial Officer | 1.1yrs | CA$325.72k | no data | |
Chief Executive Officer of Adjupharm | 4.8yrs | CA$293.97k | 0.039% $ 1.7k | |
Director Investor & Public Relations | no data | no data | no data | |
General Counsel | 1.6yrs | no data | no data |
3.2yrs
Average Tenure
Experienced Management: IMCC's management team is considered experienced (3.2 years average tenure).
Board Members
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
CEO & Director | 5.1yrs | CA$808.07k | 13.98% $ 608.0k | |
Director | less than a year | no data | no data | |
Independent Director | 2.2yrs | CA$96.66k | no data | |
Independent Director | 3.8yrs | CA$135.32k | no data | |
Independent Director | 2.2yrs | CA$93.16k | 2.74% $ 119.2k |
2.2yrs
Average Tenure
Experienced Board: IMCC's board of directors are not considered experienced ( 2.2 years average tenure), which suggests a new board.